Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - Updated to revision v3.2.0 and added a government operating-status notice. - Removed Mature T-cell and NK-cell non-Hodgkin lymphoma from current content.
    Difference
    3%
    Check dated 2025-10-05T10:20:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:19:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:48:32.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T17:34:13.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and resources related to specific types of lymphoma, while removing outdated references and certain drug classifications.
    Difference
    5%
    Check dated 2025-08-30T15:25:12.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T11:37:35.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.